Inflammatory markers such as TNF-α, high-sensitivity C-reactive protein (hsCRP), IL-1β, and IL-6 are increased in the tissues and serum of T2DM patients [7–10]. This evidence concerns the gene IL1B and type 2 diabetes mellitus.